Buy Botox Injection Online

$400.00$1,200.00

Buy Allergan Botox Injection 100 iu Online – from Planetmedssupply online Pharmacy at very affordable prices with the best quality with or without prescription. For other Brands and Milligrams of this product kindly contact our customer service through our website live chat or email us at [email protected]

Clear
SKU: N/A Category:

Description

Buy Botox Injection Online from our online store planet meds supply

Buy Botox Injection Online. Botox is a prescription injection that serves multiple purposes. It is approved for the relief of neck pain associated with cervical dystonia as well as treatment of upper limb spasticity. It is also used in removing wrinkles that occur between eyebrows, or the so-called frown lines. Botox is also used in treating severe underarm sweating, eyelid twitching and misaligned eyes like crossed eyes. It is also prescribed for the prevention of chronic migraines.

This multipurpose drug is made by Allergan Pharmaceuticals. Due to the numerous conditions it treats, the dosage of Botox varies. Other considerations that can affect the dosage of Botox include the response of the patient to the medication and other drugs he or she is currently taking. Buy Botox Injection Online

The use of Botox can cause a person to experience conditions which may last for a few days or until the body adjusts to the medication. Short-term side effects of Botox include difficulty with swallowing, breathing or speaking. Other users also complain of dryness of the eyes, inability to completely close the eyelids, and decreased blinking. Other short-term side effects of this drug are body pain, congestion, chills, diarrhea, cough, fever, headache, joint pain nausea, runny nose, and shivering.

Long-Term Side Effects

Chronic use of Botox can increase a person’s risks to side effects which could last for months or even longer. These long-term side effects include pain in the bladder caused by an overactive bladder, bloody urine, difficulty with or painful urination, and frequent urge to urinate. Long-time users of Botox also say they suffer from lower back pain, neck pain, unusual exhaustion, and skin rashes probably due to the numerous times they were injected with the drug. If these side effects persist, a patient should inform his doctor immediately. Buy Botox Injection Online

How It Works

Botox is a toxin made by the bacteria called Clostridium Botulinum. It works by lowering the nerve signals to the muscles causing the latter to relax. Botox goes inside the nerve cells, barring the production of acetylcholine which is a chemical that sends signals from one nerve to another. However, this drug won’t be able to sustain its actions. The muscle will recover and go back to its normal state. Botox works in the same way to treat severe sweating. It blocks the release of acetylcholine from the nerve cells which cause the stimulation of the sweat glands. Buy Botox Injection Online

Interactions

Certain drugs may interact negatively with Botox, causing it to become less effective or increase the risks of side effects. These drugs include aminoglycoside antibiotics like Amikin, Gentamicin, and Neo-Fradin as well as neuromuscular- blocking drugs like Nimbex, Nuromax, Mivacron, Zemuron, Norcuron, Anectine, and Tubocurarine.

Generic Alternatives

In case Botox causes long-term side effects to its user, a doctor may recommend using other drugs like PureTox, Myobloc, and Dysport. Buy Botox Injection Online

History[edit]

In 1820, Justinus Kerner, a small-town German medical officer and romantic poet, gave the first complete description of clinical botulism based on extensive clinical observations of so-called “sausage poisoning”.[45] Following experiments on animals and on himself, he concluded that the toxin acts by interrupting signal transmission in the somatic and autonomic motor systems, without affecting sensory signals or mental functions. He observed that the toxin develops under anaerobic conditions, and can be lethal in minute doses.[46] His prescience in suggesting that the toxin might be used therapeutically earned him recognition as the pioneer of modern botulinum toxin therapy.[47]

In 1895 (seventy-five years later), Émile van Ermengem, professor of bacteriology and a student of Robert Koch, correctly described Clostridium botulinum as the bacterial source of the toxin. Thirty-four attendees at a funeral were poisoned by eating partially salted ham, an extract of which was found to cause botulism-like paralysis in laboratory animals. Van Ermengem isolated and grew the bacterium, and described its toxin,[48] which was later purified by P Tessmer Snipe and Hermann Sommer.[49]

Food canning[edit]

Over the next three decades, 1895-1925, as food canning was approaching a billion-dollar-a-year industry, botulism was becoming a public health hazard. Karl Friedrich Meyer, a prodigiously productive Swiss-American veterinary scientist created a center at the Hooper Foundation in San Francisco, where he developed techniques for growing the organism and extracting the toxin, and conversely, for preventing organism growth and toxin production, and inactivating the toxin by heating. The California canning industry was thereby preserved.

World War II[edit]

With the outbreak of World War II, weaponization of botulinum toxin was investigated at Fort Detrick in Maryland. Carl Lamanna and James Duff[50] developed the concentration and crystallization techniques that Edward J. Schantz used to create the first clinical product. When the Army’s Chemical Corps was disbanded, Schantz moved to the Food Research Institute in Wisconsin, where he manufactured toxin for experimental use and generously provided it to the academic community.

The mechanism of botulinum toxin action – blocking the release from nerve endings of the neurotransmitter acetylcholine – was elucidated in the mid-1900s,[51] and remains an important research topic. Nearly all toxin treatments are based on this effect in various body tissues.

Strabismus[edit]

Ophthalmologists specializing in eye muscle disorders (strabismus) had developed the method of EMG-guided injection (using the electromyogram, the electrical signal from an activated muscle, to guide injection) of local anesthetics as a diagnostic technique for evaluating an individual muscle’s contribution to an eye movement.[52] Because strabismus surgery frequently needed repeating, a search was undertaken for non-surgical, injection treatments using various anesthetics, alcohols, enzymes, enzyme blockers, and snake neurotoxins. Finally, inspired by Daniel Drachman’s work with chicks at Johns Hopkins,[53] Alan B. Scott and colleagues injected botulinum toxin into monkey extraocular muscles.[54] The result was remarkable: a few picograms induced paralysis that was confined to the target muscle, long in duration, and without side-effects.

After working out techniques for freeze-drying, buffering with albumin, and assuring sterility, potency, and safety, Scott applied to the U.S. Food and Drug Administration (FDA) for investigational drug use, and began manufacturing botulinum type A neurotoxin in his San Francisco lab. He injected the first strabismus patients in 1977, reported its clinical utility in 1980,[55] and had soon trained hundreds of ophthalmologists in EMG-guided injection of the drug he named Oculinum (“eye aligner”).

In 1986, Oculinum Inc, Scott’s micromanufacturer and distributor of botulinum toxin, was unable to obtain product liability insurance, and could no longer supply the drug. As supplies became exhausted, patients who had come to rely on periodic injections became desperate. For 4 months, as liability issues were resolved, American blepharospasm patients traveled to Canadian eye centers for their injections.[56]

Based on data from thousands of patients collected by 240 investigators, Allergan received U.S. Food and Drug Administration (FDA) approval in 1989 to market Oculinum for clinical use in the United States to treat adult strabismus and blepharospasm, using the trademark Botox.[57] This was under the 1983 US Orphan Drug Act.[58]

Cosmetics[edit]

Richard Clark, a plastic surgeon from Sacramento (CA), was the first to document a cosmetic use for botulinum toxin.[59] He treated forehead asymmetry caused by left sided forehead nerve paralysis that occurred during a cosmetic facelift. Since the injured nerve could possibly regenerate by 24 months, a two-year waiting period was necessary before definitive surgical treatment could be done. Clark realized that botulinum toxin, which had been previously used only for cross eyed babies and facial tics, could also be injected to smooth the wrinkles of the right forehead to match her paralyzed left. He received FDA approval for this cosmetic application of the toxin and successfully treated the person and published the case study in 1989.[59]

Marrying ophthalmology to dermatology, Jean and Alistair Carruthers observed that blepharospasm patients who received injections around the eyes and upper face also enjoyed diminished facial glabellar lines (“frown lines” between the eyebrows), thereby initiating the highly-popular cosmetic use of the toxin.[60] Brin, and a group at Columbia University under Monte Keen made similar reports.[61] In 2002, following clinical trials, the U.S. Food and Drug Administration (FDA) approved Botox Cosmetic, botulinum A toxin to temporarily improve the appearance of moderate-to-severe glabellar lines.[62] The FDA approved a fully in vitro assay for use in the stability and potency testing of Botox in response to increasing public concern that LD50 testing was required for each batch sold in the market.[63][64]

Chronic pain[edit]

William J. Binder reported in 2000, that patients who had cosmetic injections around the face reported relief from chronic headache.[65] This was initially thought to be an indirect effect of reduced muscle tension, but it is now known that the toxin inhibits release of peripheral nociceptive neurotransmitters, suppressing the central pain processing systems responsible for migraine headache.[66][67]

Society and culture[edit]

Economics[edit]

As of 2018, botulinum toxin injections are the most common cosmetic operation, with 7.4 million procedures in the United States, according to the American Society of Plastic Surgeons.[68] Qualifications for Botox injectors vary by county, state and country. Botox cosmetic providers include dermatologists, plastic surgeons, aesthetic spa physicians, dentists, nurse practitioners, nurses and physician assistants.

The global market for botulinum toxin products, driven by their cosmetic applications, is forecast to reach $2.9 billion by 2018. The facial aesthetics market, of which they are a component, is forecast to reach $4.7 billion ($2 billion in the U.S.) in the same timeframe.[69]

Bioterrorism[edit]

Botulinum toxin has been recognized as a potential agent for use in bioterrorism.[70] It can be absorbed through the eyes, mucous membranes, respiratory tract, and through non-intact skin.[71]

The effects of botulinum toxin are different from those of nerve agents involved insofar in that botulism symptoms develop relatively slowly (over several days), while nerve agent effects are generally much more rapid and can be instantaneous.[citation needed] Evidence suggests that nerve exposure (simulated by injection of atropine and pralidoxime) will increase mortality by enhancing botulinum toxin’s mechanism of toxicity.[citation needed]

With regard to detection, current[when?] protocols using NBC detection equipment (such as M-8 paper or the ICAM) will not indicate a “positive” when samples containing botulinum toxin are tested.[citation needed] To confirm a diagnosis of botulinum toxin poisoning, therapeutically or to provide evidence in death investigations, botulinum toxin may be quantitated by immunoassay of human biological fluids; serum levels of 12–24 mouse LD50 units per milliliter have been detected in poisoned patients.[72]

The Japanese doomsday cult Aum Shinrikyo produced botulinum toxin and spread it as an aerosol in downtown Tokyo during the 1990s, but the attacks caused no fatalities.[73]

During the early 1980s, the German and French newspapers reported that the police had raided a Baader-Meinhof gang safe house in Paris and had found a makeshift laboratory that contained flasks full of Clostridium botulinum, which makes botulinum toxin. Their reports were later found to be incorrect; no such lab was ever found.[74]

Brand names[edit]

Botulinum toxin A is marketed under the brand names Jeuveau, Botox and Xeomin. Botulinum toxin B is marketed under the brand name Myobloc. buy botox injection online

In the United States, botulinum toxin products are manufactured by a variety of companies, for both therapeutic and cosmetic use. A U.S. supplier reported in its company materials in 2011 that it could “supply the world’s requirements for 25 indications approved by Government agencies around the world” with less than one gram of raw botulinum toxin.[75] Myobloc or Neurobloc, a botulinum toxin type B product, is produced by Solstice Neurosciences, a subsidiary of US WorldMeds. AbobotulinumtoxinA), a therapeutic formulation of the type A toxin manufactured by Galderma in the United Kingdom, is licensed for the treatment of focal dystonias and certain cosmetic uses in the U.S. and other countries. buy botox injection online from Planet meds supply.

Besides the three primary U.S. manufacturers, there are numerous other botulinum toxin producers. Xeomin, manufactured in Germany by Merz, is also available for both therapeutic and cosmetic use in the U.S.[76] Lanzhou Institute of Biological Products in China manufactures a BTX-A product; as of 2014 it was the only BTX-A approved in China.[76] BTX-A is also sold as Lantox and Prosigne on the global market.[77] Neuronox, a BTX-A product, was introduced by Medy-Tox Inc. of South Korea in 2009;[78]

Toxin production[edit]

Botulism toxins are produced by bacteria of the genus Clostridium, namely Clostridium botulinumC. butyricumC. baratii and C. argentinense,[79] which are widely distributed, including in soil and dust. As well, the bacteria can be found inside homes on floors, carpet, and countertops even after cleaning.[citation needed] Some food products such as honey can contain amounts of the bacteria. buy botox injection online

Food-borne botulism results, indirectly, from ingestion of food contaminated with Clostridium spores, where exposure to an anaerobic environment allows the spores to germinate, after which the bacteria can multiply and produce toxin.[citation needed] Critically, it is ingestion of toxin rather than spores or vegetative bacteria that causes botulism.[citation needed] Botulism is nevertheless known to be transmitted through canned foods not cooked correctly before canning or after can opening, and so is preventable.[citation needed] Infant botulism cases arise chiefly as a result of environmental exposure and are therefore more difficult to prevent.[citation needed] Infant botulism arising from consumption of honey can be prevented by eliminating honey from diets of children less than 12 months old. buy botox injection online

Organism and toxin susceptibilities[edit]

Proper refrigeration at temperatures below 3 °C (38 °F) retards the growth of Clostridium botulinum. The organism is also susceptible to high salt, high oxygen, and low pH levels.[6] The toxin itself is rapidly destroyed by heat, such as in thorough cooking.[81] The spores that produce the toxin are heat-tolerant and will survive boiling water for an extended period of time.[82]

The botulinum toxin is denatured and thus deactivated at temperatures greater than 85 °C (185 °F) for five minutes.[83] As a zinc metalloprotease (see below), the toxin’s activity is also susceptible, post-exposure, to inhibition by protease inhibitors, e.g., zinc-coordinating hydroxamates.[42][84]

Research[edit]

Blepharospasm and strabismus[edit]

University-based ophthalmologists in the US and Canada further refined the use of botulinum toxin as a therapeutic agent. By 1985, a scientific protocol of injection sites and dosage had been empirically determined for treatment of blepharospasm and strabismus.[85] Side effects in treatment of this condition were deemed to be rare, mild and treatable.[86] The beneficial effects of the injection lasted only 4–6 months. Thus, blepharospasm patients required re-injection two or three times a year. buy botox injection online

In 1986, Scott’s micromanufacturer and distributor of Botox was no longer able to supply the drug because of an inability to obtain product liability insurance. Patients became desperate, as supplies of Botox were gradually consumed, forcing him to abandon patients who would have been due for their next injection. For a period of four months, American blepharospasm patients had to arrange to have their injections performed by participating doctors at Canadian eye centers until the liability issues could be resolved.[56]

In December 1989, Botox was approved by the U.S. Food and Drug Administration (FDA) for the treatment of strabismus, blepharospasm, and hemifacial spasm in patients over 12 years old.[57]

Botox has not been approved for any pediatric use.[35] It has, however, been used off-label by physicians for several conditions. including spastic conditions in pediatric patients with cerebral palsy, a therapeutic course that has resulted in patient deaths.[35] In the case of treatment of infantile esotropia in patients younger than 12 years of age, several studies have yielded differing results.[25][better source needed]

Cosmetic[edit]

The cosmetic effect of BTX-A on wrinkles was originally documented by a plastic surgeon from Sacramento, California, Richard Clark, and published in the journal Plastic and Reconstructive Surgery in 1989.[59] Canadian husband and wife ophthalmologist and dermatologist physicians, JD and JA Carruthers, were the first to publish a study on BTX-A for the treatment of glabellar frown lines in 1992.[60] Similar effects had reportedly been observed by a number of independent groups (Brin, and the Columbia University group under Monte Keen.[61]) After formal trials, on 12 April 2002, the FDA announced regulatory approval of botulinum toxin type A (Botox Cosmetic) to temporarily improve the appearance of moderate-to-severe frown lines between the eyebrows (glabellar lines).[62] Subsequently, cosmetic use of botulinum toxin type A has become widespread.[87] The results of Botox Cosmetic can last up to four months and may vary with each patient.[88] The U.S. Food and Drug Administration (FDA) approved an alternative product-safety testing method in response to increasing public concern that LD50 testing was required for each batch sold in the market.[63][64]

BTX-A has also been used in the treatment of gummy smiles,[89][90] the material is injected into the hyperactive muscles of upper lip, which causes a reduction in the upward movement of lip thus resulting in a smile with a less exposure of gingiva.[91] Botox is usually injected in the three lip elevator muscles that converge on the lateral side of the ala of the nose; the levator labii superioris (LLS), the levator labii superioris alaeque nasi muscle (LLSAN), and the zygomaticus minor (ZMi).[92][93]

Upper motor neuron syndrome[edit]

BTX-A is now a common treatment for muscles affected by the upper motor neuron syndrome (UMNS), such as cerebral palsy, for muscles with an impaired ability to effectively lengthen. Muscles affected by UMNS frequently are limited by weakness, loss of reciprocal inhibition, decreased movement control and hypertonicity (including spasticity). In January 2014, Botulinum toxin was approved by UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for the treatment of ankle disability due to lower limb spasticity associated with stroke in adults.[23] Joint motion may be restricted by severe muscle imbalance related to the syndrome, when some muscles are markedly hypertonic, and lack effective active lengthening. Injecting an overactive muscle to decrease its level of contraction can allow improved reciprocal motion, so improved ability to move and exercise.

Cervical dystonia[edit]

BTX-A is commonly used to treat cervical dystonia, but it can become ineffective after a time. Botulinum toxin type B (BTX-B) received FDA approval for treatment of cervical dystonia on 21 December 2000. Trade names for BTX-B are Myobloc in the United States, and Neurobloc in the European Union.[76]

Chronic migraine[edit]

Onabotulinumtoxin A (trade name Botox) received FDA approval for treatment of chronic migraines on 15 October 2010. The toxin is injected into the head and neck to treat these chronic headaches. Approval followed evidence presented to the agency from two studies funded by Allergan showing a very slight improvement in incidence of chronic migraines for migraine sufferers undergoing the Botox treatment.[94][95]

Since then, several randomized control trials have shown botulinum toxin type A to improve headache symptoms and quality of life when used prophylactically for patients with chronic migraine[96] who exhibit headache characteristics consistent with: pressure perceived from outside source, shorter total duration of chronic migraines (<30 years), “detoxification” of patients with coexisting chronic daily headache due to medication overuse, and no current history of other preventive headache medications. buy botox injection online usa

Additional information

QUANTITY

10 vails 50 iu, 10 vails 100 iu, 10 vails 200 iu